Loading clinical trials...
Loading clinical trials...
The purpose of this study is to learn about the natural progression of DCM (dilated cardiomyopathy) caused by BAG3 gene mutations. DCM is a condition as the heart muscle is weakened and the heart beco...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alexion Pharmaceuticals, Inc.
NCT05321875 · Cardiomyopathy, Dilated
NCT03533517 · Heart Failure, Cardiomyopathy, Dilated
NCT02352129 · Cardiomyopathy, Dilated
NCT07491237 · Arrhythmia, Cardiomyopathy, Dilated, and more
NCT06039072 · Cardiomyopathy, Dilated
Research Site
Palo Alto, California
Research Site
Aurora, Colorado
Research Site
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions